BackgroundCheck.run
Search For

George J BrozeSaint Louis, MO

George Broze Phones & Addresses

Saint Louis, MO   

15 W Point Ln, Saint Louis, MO 63131   

Social networks

George J Broze

Linkedin

Work

Company: Saint Louis Office Address: 660 S Euclid Ave, Saint Louis, MO 63110 Phones: 314-3625000 (Phone) 314-4545396 (Fax)

Education

School / High School: Univ Of Wa Sch Of Med 1972

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Internal Medicine, 1976

Industries

Research

Mentions for George J Broze

Career records & work history

Medicine Doctors

George Broze Photo 1

Dr. George J Broze, Saint Louis MO - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
660 S Euclid Ave Suite 8125, Saint Louis, MO 63110
314-7473000 (Phone) 314-3628826 (Fax)
Saint Louis Office
660 S Euclid Ave, Saint Louis, MO 63110
314-3625000 (Phone) 314-4545396 (Fax)
SITEMAN CANCER CENTER
4921 Parkview Pl Suite 7Th, Saint Louis, MO 63110
314-7471171 (Phone) 314-3627086 (Fax)
Certifications:
Internal Medicine, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Univ Of Wa Sch Of Med
Graduated: 1972
Medical School
University Of Nc Hosps
Graduated: 1972
George Broze Photo 2

George Broze, Saint Louis MO

Work:
Washington University at St. Louis
4921 Parkview Pl, Saint Louis, MO 63110Washington University at St. Louis
660 S Euclid Ave, Saint Louis, MO 63110
George Broze Photo 3

George John Broze, Saint Louis MO

Specialties:
Internist
Address:
4939 Childrens Pl, Saint Louis, MO 63110
4921 Parkview Pl, Saint Louis, MO 63110
660 S Euclid Ave, Saint Louis, MO 63110
Education:
University of Washington, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine

George Broze resumes & CV records

Resumes

George Broze Photo 17

Professor

Location:
Saint Louis, MO
Industry:
Research
Work:
Washington University In St. Louis
Professor

Publications & IP owners

Us Patents

Method For Using Lipoprotein Associated Coagulation Inhibitor To Treat Sepsis

US Patent:
7662774, Feb 16, 2010
Filed:
Jul 15, 2004
Appl. No.:
10/891493
Inventors:
Abla A. Creasey - Piedmont CA, US
George J. Broze - Ladue MO, US
Assignee:
Novartis Vaccines and Diagnostics, Inc. - Emeryville CA
International Classification:
C07K 14/00
US Classification:
514 2, 530350
Abstract:
A method for prophylactically or therapeutically treating sepsis or septic shock is described, wherein an inhibitor to tissue factor is administered to septic patients. Additionally, a method for treating inflammation is described wherein the inhibitor is administered to patients. This inhibitor is termed lipoprotein associated coagulation inhibitor, or commonly LACI. It is 38 kD and has 276 amino acids. LACI has now been shown to be useful for the treatment of sepsis, septic shock and inflammation.

Methods And Compositions For Inhibition Of Hepatic Clearance Of Tissue Factor Pathway Inhibitor

US Patent:
5650391, Jul 22, 1997
Filed:
Mar 21, 1994
Appl. No.:
8/216593
Inventors:
Alan L. Schwartz - Clayton MO
Ilka Warshawsky - St. Louis MO
George J. Broze - Ladue MO
Assignee:
Jewish Hospital of St. Louis - St. Louis MO
International Classification:
A61K 3816
US Classification:
514 12
Abstract:
The present invention discloses methods and compositions for inhibiting the hepatic clearance of Tissue Factor Pathway Inhibitor (TFPI) using receptor-associated protein.

Method For Using Lipoprotein Associated Coagulation Inhibitor To Treat Sepsis

US Patent:
6063764, May 16, 2000
Filed:
Jun 7, 1995
Appl. No.:
8/472761
Inventors:
Abla A. Creasey - Piedmont CA
George J. Broze - Ladue MO
Assignee:
Washington University & Chiron Corp.
International Classification:
A61K 3800
US Classification:
514 12
Abstract:
A method for prophylactically or therapeutically treating sepsis or septic shock is described, wherein an inhibitor to tissue factor is administered to septic patients. Additionally, a method for treating inflammation is described wherein the inhibitor is administered to pateints. This inhibitor is termed lipoprotein associated coagulation inhibitor, or commonly LACI. It is 38 kD and has 276 amino acids. LACI has now been shown to be useful for the treatment of sepsis, septic shock and inflammation.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.